Global Product Portfolio

Below is a list of the treatments we currently offer via our Innovative Medicines Division. Visit Sandoz and Advanced Accelerator Applications to learn about our generics and radiopharmaceutical products.
Please note: Not all treatments are available in all countries.

A B C D E F G I J K L M N O P R S T U V X Z

aldesleukin

Proleukin®

aldesleukin
Oncology
Oncology
USA Product Site Germany United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Netherlands Canada Turkey

alpelisib

Piqray®

alpelisib
Oncology
Oncology
USA Product Site USA

amlodipine besylate

Exforge HCT®

valsartan, amlodipine besylate, hydrochlorothiazide
Cardiovascular, Renal and Metabolism
Established Medicines
USA Product Site USA Finland Germany Australia Austria Poland Turkey Japan

Exforge®

valsartan, amlodipine besylate
Cardiovascular, Renal and Metabolism
Established Medicines
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Turkey

basiliximab

Simulect®

basiliximab
Immunology and Dermatology
Immunology and Dermatology
Global Product Site USA Finland Germany United Kingdom Austria Poland Netherlands Canada Turkey

benazepril hydrochloride

Cibacen®

benazepril hydrochloride
Cardiovascular, Renal and Metabolism
Established Medicines

brimonidine tartrate

Simbrinza®

brinzolamide, brimonidine tartrate
Ophthalmology
Ophthalmology
Global Product Site USA Germany Australia Austria Poland Netherlands Canada

brinzolamide

Azarga®/Azorga®

brinzolamide, timolol
Ophthalmology
Ophthalmology
Germany Australia Austria Poland Netherlands Canada Japan

Simbrinza®

brinzolamide, brimonidine tartrate
Ophthalmology
Ophthalmology
Global Product Site USA Germany Australia Austria Poland Netherlands Canada

brolucizumab

Beovu®

brolucizumab
Ophthalmology
Ophthalmology
Global USA

canakinumab

Ilaris®

canakinumab
Immunology and Dermatology
Immunology and Dermatology
USA Product Site USA Germany United Kingdom Austria Poland Netherlands Canada Turkey Japan

capmatinib

Tabrecta™

capmatinib
Oncology
Oncology
USA Product Site

carbamazepine

Tegretol®

carbamazepine
Neuroscience
Established Medicines
Global Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

carbidopa

Stalevo®

carbidopa, levodopa, entacapone
Neuroscience
Established Medicines
Global Product Site USA Australia Austria Netherlands Canada Turkey Japan

ceritinib

Zykadia®

ceritinib
Global Product Site US Product Site USA

Zykadia®

ceritinib
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey

ciprofloxacin

Ciprodex®

ciprofloxacin, dexamethasone
Ophthalmology
Ophthalmology
Global Product Site USA Canada

crizanlizumab

Adakveo®

crizanlizumab
Oncology
Oncology
Global Product Site US Product Site USA

cyclosporine

Neoral®/Sandimmune®

cyclosporine, USP Modified
Immunology and Dermatology
Immunology and Dermatology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

dabrafenib

Tafinlar®

dabrafenib
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

deferasirox

Exjade®

deferasirox
Oncology
Oncology
Global Product Site USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Jadenu®

deferasirox
Oncology
Oncology
Global Product Site USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

dexamethasone

Ciprodex®

ciprofloxacin, dexamethasone
Ophthalmology
Ophthalmology
Global Product Site USA Canada

Tobradex®

tobramycin, dexamethasone
Ophthalmology
Ophthalmology
USA Germany Austria Poland Netherlands Canada

dexmethylphenidate extended release

Focalin®

dexmethylphenidate HCl, dexmethylphenidate extended release
Neuroscience
Established Medicines
USA Product Site USA

Focalin® XR

dexmethylphenidate HCl, dexmethylphenidate extended release
Neuroscience
Established Medicines
USA Product Site USA

dexmethylphenidate HCl

Focalin®

dexmethylphenidate HCl, dexmethylphenidate extended release
Neuroscience
Established Medicines
USA Product Site USA

Focalin® XR

dexmethylphenidate HCl, dexmethylphenidate extended release
Neuroscience
Established Medicines
USA Product Site USA

difluprednate

Durezol®

difluprednate
Ophthalmology
Ophthalmology
Global Product Site USA Canada

eltrombopag

Promacta®/Revolade®

eltrombopag
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Canada Turkey Japan

entacapone

Comtan®

entacapone
Neuroscience
Established Medicines
Global Product Site USA Australia Netherlands Canada Turkey Japan

Stalevo®

carbidopa, levodopa, entacapone
Neuroscience
Established Medicines
Global Product Site USA Australia Austria Netherlands Canada Turkey Japan

erenumab

Aimovig®

erenumab
Neuroscience
Neuroscience
USA Product Site USA

everolimus

Afinitor Disperz®/Votubia®

everolimus
Oncology
Oncology
Global Product Site USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey

Afinitor®/Votubia®

everolimus
Oncology
Oncology
Global Product Site USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey

Zortress®/Certican®

everolimus
Immunology and Dermatology
Immunology and Dermatology
Global Product Site USA Product Site USA Germany Australia United Kingdom Austria Poland Netherlands Turkey

fingolimod

Gilenya®

fingolimod
Neuroscience
Neuroscience
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Japan

fluvastatin sodium

Lescol®

fluvastatin sodium
Cardiovascular, Renal and Metabolism
Established Medicines
Global Product Site USA Australia United Kingdom Austria Poland Netherlands Canada

Lescol® XL

fluvastatin sodium
Cardiovascular, Renal and Metabolism
Established Medicines
Global Product Site USA Australia United Kingdom Austria Poland Netherlands Canada

glycopyrronium bromide

Seebri Breezhaler®

glycopyrronium bromide
Respiratory
Respiratory
Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Japan

Ultibro® Breezhaler®

indacaterol, glycopyrronium bromide
Respiratory
Respiratory
Finland Germany Australia United Kingdom Austria Poland Netherlands Canada

hyaluronic acid

Systane® Hydration

polyethylene glycol 400, propylene glycol, hyaluronic acid
Ophthalmology
Ophthalmology
Global Product Site

hydrochlorothiazide

Diovan HCT® /Co-Diovan®

valsartan, hydrochlorothiazide
Cardiovascular, Renal and Metabolism
Established Medicines
USA Product Site USA Finland Austria Poland Netherlands Canada Turkey

Exforge HCT®

valsartan, amlodipine besylate, hydrochlorothiazide
Cardiovascular, Renal and Metabolism
Established Medicines
USA Product Site USA Finland Germany Australia Austria Poland Turkey Japan

imatinib mesylate

Gleevec®/Glivec®

imatinib mesylate
Oncology
Oncology
Global Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

indacaterol

Onbrez® Breezhaler®

indacaterol
Respiratory
Respiratory
Finland Germany Australia United Kingdom Poland Netherlands Canada Turkey Japan

Ultibro® Breezhaler®

indacaterol, glycopyrronium bromide
Respiratory
Respiratory
Finland Germany Australia United Kingdom Austria Poland Netherlands Canada

interferon beta-1b

Extavia®

interferon beta-1b
Neuroscience
Neuroscience
USA Product Site USA Finland Germany United Kingdom Poland Canada

lapatinib

Tyverb®

lapatinib
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Canada Turkey Japan

letrozole

Femara®

letrozole
Oncology
Oncology
USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Netherlands Canada Turkey Japan

levodopa

Stalevo®

carbidopa, levodopa, entacapone
Neuroscience
Established Medicines
Global Product Site USA Australia Austria Netherlands Canada Turkey Japan

metformin

Eucreas®

vildagliptin, metformin
Cardiovascular, Renal and Metabolism
Respiratory
Global Product Site Finland United Kingdom Austria Poland Netherlands

methylphenidate HCl

Ritalin®

methylphenidate HCl
Neuroscience
Established Medicines
Global Product Site USA Finland Germany Australia United Kingdom Austria Netherlands Canada Turkey Japan

methylphenidate HCl modified release

Ritalin LA®

methylphenidate HCl modified release
Neuroscience
Established Medicines
USA Australia

midostaurin

Rydapt®

midostaurin
Oncology
Oncology
Global Product Site USA Product Site

mycophenolic acid (as mycophenolate sodium)

Myfortic®

mycophenolic acid (as mycophenolate sodium)
Immunology and Dermatology
Immunology and Dermatology
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey

nepafenac

Ilevro®/Nevanac®

nepafenac
Ophthalmology
Ophthalmology
Global Product Site USA Germany Canada Australia Austria Poland Netherlands

nilotinib

Tasigna®

nilotinib
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

octreotide acetate

Sandostatin LAR®

octreotide acetate
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Poland Netherlands Canada Turkey Japan

Sandostatin® SC

octreotide acetate
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Poland Netherlands Canada Turkey Japan

ofatumumab

Arzerra®

ofatumumab
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Kesimpta®

ofatumumab
Neuroscience
Neuroscience
USA Product Site USA

olopatadine

Pataday™

olopatadine
Ophthalmology
Ophthalmology
Global Product Site USA Canada

Patanol®

olopatadine
Ophthalmology
Ophthalmology
Global Product Site USA Product Site USA Australia Poland Netherlands Canada Japan

Pazeo®

olopatadine
Ophthalmology
Ophthalmology
Global Product Site USA Canada

omalizumab

Xolair®

omalizumab
Immunology and Dermatology
Immunology and Dermatology
Global Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey

oxcarbazepine

Trileptal®

oxcarbazepine
Neuroscience
Established Medicines
Global Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey

panobinostat

Farydak®

panobinostat
Oncology
Oncology
Global Product Site USA Germany Austria Poland Netherlands

pazopanib

Votrient®

pazopanib
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

polyethylene glycol 400

Systane®

polyethylene glycol 400, propylene glycol
Ophthalmology
Ophthalmology
Global Product Site

Systane® Hydration

polyethylene glycol 400, propylene glycol, hyaluronic acid
Ophthalmology
Ophthalmology
Global Product Site

Systane® Ultra

polyethylene glycol 400, propylene glycol
Ophthalmology
Ophthalmology
Global Product Site

propylene glycol

Systane®

polyethylene glycol 400, propylene glycol
Ophthalmology
Ophthalmology
Global Product Site

Systane® Balance

propylene glycol
Ophthalmology
Ophthalmology
Global Product Site

Systane® Hydration

polyethylene glycol 400, propylene glycol, hyaluronic acid
Ophthalmology
Ophthalmology
Global Product Site

Systane® Ultra

polyethylene glycol 400, propylene glycol
Ophthalmology
Ophthalmology
Global Product Site

ranibizumab

Lucentis®

ranibizumab
Ophthalmology
Ophthalmology
Global Product Site Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

ribociclib

Kisqali®

ribociclib
Oncology
Oncology
Global Product Site USA Product Site

rivastigmine

Exelon®

rivastigmine
Neuroscience
Established Medicines
USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

ruxolitinib

Jakavi®

ruxolitinib
Oncology
Oncology
Global Product Site Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

sacubitril

Entresto®

sacubitril, valsartan
Cardiovascular, Renal and Metabolism
Cardiovascular, Renal and Metabolism
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada

secukinumab

Cosentyx®

secukinumab
Immunology and Dermatology
Immunology and Dermatology
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada

siponimod

Mayzent®

siponimod
Neuroscience
Neuroscience
USA Product Site USA

terbinafine (terbinafine hydrochloride)

Lamisil®

terbinafine (terbinafine hydrochloride)
Infectious disease
Established Medicines
USA Germany Australia United Kingdom Poland Canada Turkey

timolol

Azarga®/Azorga®

brinzolamide, timolol
Ophthalmology
Ophthalmology
Germany Australia Austria Poland Netherlands Canada Japan

Duotrav™

travoprost, timolol
Ophthalmology
Ophthalmology
Germany Australia Austria Poland Netherlands Canada Japan

tisagenlecleucel-T

Kymriah™

tisagenlecleucel-T
Oncology
Oncology
Global Product Site USA Product Site

tobramycin

TOBI®

tobramycin
Respiratory
Established Medicines
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

TOBI® Podhaler™

tobramycin
Respiratory
Established Medicines
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

Tobradex®

tobramycin, dexamethasone
Ophthalmology
Ophthalmology
USA Germany Austria Poland Netherlands Canada

trametinib

Mekinist®

trametinib
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

travoprost

Duotrav™

travoprost, timolol
Ophthalmology
Ophthalmology
Germany Australia Austria Poland Netherlands Canada Japan

Izba®

travoprost
Ophthalmology
Ophthalmology
Global Product Site USA Germany Australia Austria Poland Netherlands Canada Japan

Travatan Z®

travoprost
Ophthalmology
Ophthalmology
Global Product Site USA Germany Australia Austria Poland Netherlands Canada Japan

Travatan®

travoprost
Ophthalmology
Ophthalmology
Global Product Site USA Germany Australia Austria Poland Netherlands Canada Japan

Travatan® BAK-Free

travoprost
Ophthalmology
Ophthalmology
Global Product Site USA Germany Australia Austria Poland Netherlands Canada Japan

triclabendazole

Egaten®

triclabendazole
Hepatology
Established Medicines
USA

USP Modified

Neoral®/Sandimmune®

cyclosporine, USP Modified
Immunology and Dermatology
Immunology and Dermatology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

valsartan

Diovan HCT® /Co-Diovan®

valsartan, hydrochlorothiazide
Cardiovascular, Renal and Metabolism
Established Medicines
USA Product Site USA Finland Austria Poland Netherlands Canada Turkey

Diovan®

valsartan
Cardiovascular, Renal and Metabolism
Established Medicines
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Turkey Japan

Entresto®

sacubitril, valsartan
Cardiovascular, Renal and Metabolism
Cardiovascular, Renal and Metabolism
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada

Exforge HCT®

valsartan, amlodipine besylate, hydrochlorothiazide
Cardiovascular, Renal and Metabolism
Established Medicines
USA Product Site USA Finland Germany Australia Austria Poland Turkey Japan

Exforge®

valsartan, amlodipine besylate
Cardiovascular, Renal and Metabolism
Established Medicines
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Turkey

vildagliptin

Eucreas®

vildagliptin, metformin
Cardiovascular, Renal and Metabolism
Respiratory
Global Product Site Finland United Kingdom Austria Poland Netherlands

Galvus®

vildagliptin
Cardiovascular, Renal and Metabolism
Established Medicines
Global Product Site Finland Australia United Kingdom Austria Poland Netherlands Turkey

voretigene neparvovec

Luxturna®

voretigene neparvovec
Ophthalmology
Ophthalmology
USA Product Site USA

zoledronic acid

Zometa®

zoledronic acid
Oncology
Oncology
USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan